Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study

Int J Chron Obstruct Pulmon Dis. 2021 Oct 7:16:2769-2781. doi: 10.2147/COPD.S328030. eCollection 2021.

Abstract

Background: Readmission following COPD exacerbation is a common and challenging clinical problem. New approaches to predicting readmissions are required to help mitigate risk and develop novel interventions.

Methods: We conducted a prospective cohort study in 82 COPD patients admitted due to an exacerbation of COPD. Lung function measures [spirometry, forced oscillation technique (FOT) indices and peak inspiratory flow rate (PIFR)], inflammatory biomarkers and patient-reported outcomes including previous exacerbation history, breathlessness, quality of life and frailty were measured at admission and discharge. We prospectively followed patients for 30 and 90 days to identify predictors for readmission.

Results: The readmission rate within 30 days was 38%, and 56% within 90 days. Previous exacerbations, higher COPD Assessment Test score at discharge, frailty, reduced PIFR and increased length of stay were significantly associated with 30-day readmission. PIFR at discharge and frailty had the highest predictive ability for 30-day readmission using area under receiver operating characteristic curves (AUC 0.86, 95% CI 0.78-0.95, p < 0.001 and AUC 0.81, 95% CI 0.71-0.90, p < 0.001, respectively). Ninety-day readmissions were significantly associated with previous exacerbations and hospitalisations, higher CAT score at discharge, frailty, depression, lower PIFR and greater expiratory flow limitation (EFL) in the supine position. The best predictive variable in multivariable analysis for both 30- and 90-day readmission was PIFR at discharge.

Conclusion: PIFR, CAT score, frailty, and EFL were found to be associated with 30- and 90-day readmission following COPD exacerbation. These findings help identify those at highest risk and to optimise care prior to discharge.

Keywords: COPD; EFL; PIFR; admission; exacerbation; frailty; predictor; readmission; risk factor.

MeSH terms

  • Disease Progression
  • Humans
  • Patient Readmission
  • Prospective Studies
  • Pulmonary Disease, Chronic Obstructive* / diagnosis
  • Pulmonary Disease, Chronic Obstructive* / therapy
  • Quality of Life
  • Risk Factors
  • Spirometry

Grants and funding

This trial was conducted as part of a PhD funded in association with Prince Sultan Military College of Health Sciences (PSMCHS) (Dammam, Saudi Arabia) through the Saudi Arabian Cultural Bureau (London, UK).